A point mutation in CD28 distinguishes proliferative signals from survival signals.
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Upon interaction with its ligand, B7, CD28 becomes phosphorylated on tyrosines. One tyrosine in particular (Y170 in mouse CD28, Y173 in human CD28) has received much attention. This is because it permits CD28 to recruit SH2-containing signaling molecules, including phosphoinositide 3 kinase, Grb2 and Gads. Using mice we employed a transgenic approach to express a tyrosine-->phenylalanine mutant form of CD28 that uncouples these SH2-mediated interactions from CD28. The CD28 mutant is unable to up-regulate expression of the prosurvival protein Bcl-xL, rendering the T cells more susceptible to radiation-induced death. Nonetheless, this mutated form of CD28 still prevents the induction of anergy and promotes T cell proliferation, interleukin 2 secretion and B cell help. Thus, we describe a single point mutation within the CD28 cytoplasmic domain that uncouples signals required for proliferation and survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This suggests that PI3K or its downstream effector AKT [34], [35] is mandatory (although not sufficient) for CD28SA-mediated IFN-γ production.”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [35]
Citations
Cites
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717 · cited 1×
“gif" NDATA ITEM> ]> CD28 provides costimulatory signals to T cells that prevent the induction of anergy and cell death and promote interleukin 2 (IL-2) production and clonal expansio”
BackgroundSH2 domains recognize specific phosphopeptide sequences
Zhou, S. (1993) · Cell · doi:10.1016/0092-8674(93)90404-e · Cited by 2,631 · cited 1×
“Class I A PI3Ks assemble into larger protein complexes via interaction of the p85 SH2 domains with tyrosine-phosphorylated YxxM motifs that are present on a number of cell-surface receptors and cytosolic protein”
The PI3K‒PDK1 connection: more than just a road to PKB
Vanhaesebroeck, B., & Alessi, D. R. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460561 · Cited by 1,644 · cited 1×
“To determine whether CD28-dependent activation of the PI3K pathway was abrogated in Y170F Tg mice, we assessed the phorphorylation state of PKB after CD28 stimulation as a surrogate indicator of phosphatidyl inositol-3-phosphate lipid productio”
MethodDifferential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257 · cited 1×
“Because CD28 is required for a secondary humoral respons”
BackgroundSelf-citationCD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,210 · cited 1×
“CD28-mediated up-regulation of Bcl-x L expression CD28 promotes T cell survival and may do so by increasing the expression of Bcl-x L”
BackgroundFunction of PI3Kγ in Thymocyte Development, T Cell Activation, and Neutrophil Migration
Sasaki, T., Irie-Sasaki, J., Jones, R. G., Oliveira-dos-Santos, A. J., Stanford, W. L., Bolon, B., Wakeham, A., Itie, A., Bouchard, D., Kozieradzki, I., et al. (2000) · Science · doi:10.1126/science.287.5455.1040 · Cited by 1,031 · cited 1×
“Mice that are deficient in p110γ, a PI3K family member which does not require p85 for its recruitment to receptors, produce reduced amounts of interferon γ and IL-2 in response to CD3 and CD28 stimulatio”
BackgroundSelf-citationPhosphoinositide 3-kinases: A conserved family of signal transducers
Vanhaesebroeck, B., Leevers, S. J., Panayotou, G., & Waterfield, M. D. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01061-x · Cited by 954 · cited 1×
“Class 1 A PI3Ks are heterodimeric proteins that consist of a p110α, β or δ catalytic subunit and a p85 α, β or p55γ regulatory subuni”
BackgroundSignaling by Distinct Classes of Phosphoinositide 3-Kinases
Vanhaesebroeck, B., & Waterfield, M. D. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4701 · Cited by 853 · cited 1×
“Protein kinase B (or PKB, also known as Akt), Vav and Itk are examples of signaling proteins that require PI3K for their activatio”
BackgroundImpaired B Cell Development and Proliferation in Absence of Phosphoinositide 3-Kinase p85α
Fruman, D. A., Snapper, S. B., Yballe, C. M., Davidson, L., Yu, J. Y., Alt, F. W., & Cantley, L. C. (1999) · Science · doi:10.1126/science.283.5400.393 · Cited by 516 · cited 1×
“In contrast, T cells from mice that lack expression of the p85 subunit of PI3K respond normally to CD3 and CD28 stimulatio”
BackgroundBinding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling
Pagès, F., Ragueneau, M., Rottapel, R., Truneh, A., Nunes, J., Imbert, J., & Olive, D. (1994) · Nature · doi:10.1038/369327a0 · Cited by 398
Self-citation
Cited by
The CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475
Xiao, C., Srinivasan, L., Calado, D. P., Patterson, H. C., Zhang, B., Wang, J., Henderson, J. M., Kutok, J. L., & Rajewsky, K. (2008) · Nature Immunology · doi:10.1038/ni1575 · Cited by 1,228
Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J., & Waterfield, M. D. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.615 · Cited by 1,204
Self-citationImpaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice
Okkenhaug, K., Bilancio, A., Farjot, G., Priddle, H., Sancho, S., Peskett, E., Pearce, W., Meek, S. E., Salpekar, A., Waterfield, M. D., et al. (2002) · Science · doi:10.1126/science.1073560 · Cited by 946
Self-citationCD28 Costimulation: From Mechanism to Therapy
Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A., & Bluestone, J. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.020 · Cited by 937
“…to the +3 methionine of the CD28 sequence, YMNM, which confers PI3K specificity, the +2 asparagine confers specificity for the adaptor proteins GRB2 and GADS on CD28 (Cai et al., 1995; Kim et al., 1998; Okkenhaug and Rottapel, 1998; Okkenhaug et al., 2001; Raab et al., 1995; Stein et al., 1994).”
BackgroundT-cell regulation by CD28 and CTLA-4
Alegre, M.-L., Frauwirth, K. A., & Thompson, C. B. (2001) · Nature Reviews Immunology · doi:10.1038/35105024 · Cited by 914
Carreno, B. M., & Collins, M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.091101.091806 · Cited by 896
CD28 and CTLA-4 coreceptor expression and signal transduction
Rudd, C. E., Taylor, A., & Schneider, H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00770.x · Cited by 898
“loss of PI3K binding alone) interferes with the induction of IL-2 in T-cell hybridomas (37, 78–80), while in vivo responses showed either no (81) or partial dependency on CD28–PI3K (82, 83).”
BackgroundInfluentialPI3K in lymphocyte development, differentiation and activation
Okkenhaug, K., & Vanhaesebroeck, B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1056 · Cited by 810
Self-citationCD28-mediated co-stimulation: a quantitative support for TCR signalling.
Acuto, O., & Michel, F. (2003) · Nature Reviews Immunology · doi:10.1038/nri1248 · Cited by 775
Tai, X., Cowan, M., Feigenbaum, L., & Singer, A. (2005) · Nature Immunology · doi:10.1038/ni1160 · Cited by 613
The role of PI3K in immune cells
Koyasu, S. (2003) · Nature Immunology · doi:10.1038/ni0403-313 · Cited by 487
Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling.
Rudd, C. E., & Schneider, H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1131 · Cited by 392
Bour‐Jordan, H., Esensten, J. H., Martinez‐Llordella, M., Penaranda, C., Stumpf, M., & Bluestone, J. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01011.x · Cited by 391
“of survival factor Bcl-XL map to separate regions of the CD28 cytoplasmic domain (44, 45).”
BackgroundHendriks, J., Xiao, Y., & Borst, J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030916 · Cited by 376
P hosphoinositide 3-K inase : Diverse Roles in Immune Cell Activation
Deane, J. A., & Fruman, D. A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104721 · Cited by 346
The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation
Riley, J. L., & June, C. H. (2005) · Blood · doi:10.1182/blood-2004-04-1596 · Cited by 315
T cell anergy and costimulation
Appleman, L. J., & Boussiotis, V. A. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00009.x · Cited by 305
The role of CD28 and cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) in regulatory T‐cell biology
Sansom, D. M., & Walker, L. S. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00419.x · Cited by 293
“CD28 signals also result in the upregulation of anti-apoptotic proteins such as Bcl-XL (42, 43).”
BackgroundRethinking peripheral T cell tolerance: checkpoints across a T cell’s journey
ElTanbouly, M. A., & Noelle, R. J. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00454-2 · Cited by 265
Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
Kishore, M., Cheung, K. C. P., Fu, H., Bonacina, F., Wang, G., Coe, D., Ward, E. J., Colamatteo, A., Jangani, M., Baragetti, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.10.017 · Cited by 276
“…mice The Jackson laboratory 000651 Foxp3-GFP (Foxp3-IRES-EGFP) genetically targeted mice Dr B Malissen NA Cd28Y170F Dr Klaus Okkenhaug (Okkenhaug et al., 2001) Oligonucleotides Glucokinase (hexokinase 4) primer: F:CAACTGGACCAAGGGCTTCAA; R:TGTGGCCACCGTGTCATTC this paper NA Glut1:…”
BackgroundSelf-citationAn Enigmatic Tail of CD28 Signaling
Boomer, J. S., & Green, J. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002436 · Cited by 283
“The overexpression of PKB led to constitutively elevated amounts of Bcl-XL protein and inhibited FAS mediated apoptosis (Jones et al. 2000; Jones et al. 2002).”
BackgroundInfluentialActivation and inhibition of lymphocytes by costimulation
Frauwirth, K. A., & Thompson, C. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214941 · Cited by 283
Azathioprine: old drug, new actions
Maltzman, J. S., & Koretzky, G. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18384 · Cited by 268
Hendriks, J., Xiao, Y., Rossen, J. W. A., van der Sluijs, K. F., Sugamura, K., Ishii, N., & Borst, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1665 · Cited by 212
Okkenhaug, K., Patton, D. T., Bilancio, A., Garçon, F., Rowan, W. C., & Vanhaesebroeck, B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5122 · Cited by 205
Self-citationPhosphoinositide 3-kinase in immunological systems
Fruman, D. A., & Cantley, L. C. (2002) · Seminars in Immunology · doi:10.1006/smim.2001.0337 · Cited by 204
The role of CD95 in the regulation of peripheral T‐cell apoptosis
Krueger, A., Fas, S. C., Baumann, S., & Krammer, P. H. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00047.x · Cited by 204
“However, the requirement for PI3K remains somewhat controversial (112, 113).”
BackgroundAppleman, L. J., van Puijenbroek, A. A. F. L., Shu, K. M., Nadler, L. M., & Boussiotis, V. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2729 · Cited by 201
Gelman, A. E., LaRosa, D. F., Zhang, J., Walsh, P. T., Choi, Y., Sunyer, J. O., & Turka, L. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.023 · Cited by 202
“Interestingly, this model for MyD88-mediated PI-3 kinase activation and proliferation is in contrast to results found in a mouse model with a CD28 transgene with a targeted Y170F SH2 mutation (Okkenhaug et al., 2001).”
ResultRathmell, J. C., Elstrom, R. L., Cinalli, R. M., & Thompson, C. B. (2003) · European Journal of Immunology · doi:10.1002/eji.200324048 · Cited by 196
The role of apoptosis in the development and function of T lymphocytes
ZHANG, N., HARTIG, H., DZHAGALOV, I., DRAPER, D., & HE, Y. W. (2005) · Cell Research · doi:10.1038/sj.cr.7290345 · Cited by 177
Parry, R. V., Rumbley, C. A., Vandenberghe, L. H., June, C. H., & Riley, J. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.166 · Cited by 169
“Furthermore, murine T cells expressing mutant CD28 cytoplasmic tails unable to bind PI3K have been reported to express normal levels of IL-2 (22).”
BackgroundResultGarçon, F., Patton, D. T., Emery, J. L., Hirsch, E., Rottapel, R., Sasaki, T., & Okkenhaug, K. (2008) · Blood · doi:10.1182/blood-2007-08-108050 · Cited by 153
Self-citationHomeostatic control of lymphocyte survival: potential origins and implications
Plas, D. R., Rathmell, J. C., & Thompson, C. B. (2002) · Nature Immunology · doi:10.1038/ni0602-515 · Cited by 175
Dawson, N. A. J., Rosado-Sánchez, I., Novakovsky, G. E., Fung, V. C. W., Huang, Q., McIver, E., Sun, G., Gillies, J., Speck, M., Orban, P. C., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz3866 · Cited by 147
Co-Stimulatory Receptor Signaling in CAR-T Cells
Honikel, M. M., & Olejniczak, S. H. (2022) · Biomolecules · doi:10.3390/biom12091303 · Cited by 162
Colombetti, S., Basso, V., Mueller, D. L., & Mondino, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.2730 · Cited by 138
The Physiologic Role of CD19 Cytoplasmic Tyrosines
Wang, Y., Brooks, S. R., Li, X., Anzelon-Mills, A. N., Rickert, R. C., & Carter, R. H. (2002) · Immunity · doi:10.1016/s1074-7613(02)00426-0 · Cited by 144
Jones, R. G., Elford, A. R., Parsons, M. J., Wu, L., Krawczyk, C. M., Yeh, W.-C., Hakem, R., Rottapel, R., Woodgett, J. R., & Ohashi, P. S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020307 · Cited by 139
Self-citationPI 3-K and T-cell activation: limitations of T-leukemic cell lines as signaling models
Astoul, E. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01973-1 · Cited by 135
Marktel, S., Magnani, Z., Ciceri, F., Cazzaniga, S., Riddell, S. R., Traversari, C., Bordignon, C., & Bonini, C. (2003) · Blood · doi:10.1182/blood-2002-08-2351 · Cited by 126
Markiewicz, M. A., Carayannopoulos, L. N., Naidenko, O. V., Matsui, K., Burack, R., Wise, E. L., Fremont, D. H., Allen, P. M., Yokoyama, W. M., Colonna, M., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2825 · Cited by 126
The Role of the PI3K Signaling Pathway in CD4+ T Cell Differentiation and Function
Han, J. M., Patterson, S. J., & Levings, M. K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00245 · Cited by 118
“In conventional T cells, CD28-mediated activation of the PI3K pathway is necessary for the induction of anti-apoptotic proteins (Okkenhaug et al., 2001), and the induction of glucose uptake via surface expression of GLUT1 glucose transporter (Frauwirth et al., 2002; Jacobs et al., 2008), suggesting…”
BackgroundCD28 Signaling via VAV/SLP-76 Adaptors
Raab, M., Pfister, S. M., & Rudd, C. E. (2001) · Immunity · doi:10.1016/s1074-7613(01)00248-5 · Cited by 127
Liang, Y., Cucchetti, M., Roncagalli, R., Yokosuka, T., Malzac, A., Bertosio, E., Imbert, J., Nijman, I. J., Suchánek, M., Saito, T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2634 · Cited by 117
Dynamic regulation of T‐cell costimulation through TCR–CD28 microclusters
Yokosuka, T., & Saito, T. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00779.x · Cited by 106
“However, CD28 with a tyrosine 189 mutated to phenylalanine (Y189F), which assembled with PI3K, Grb2, Gads, and Vav1 (114), and the deletion mutant of the C-terminal 16 amino acids (D16), which assembled with Lck, Itk, and lipid raft components (115), demonstrated very weak association with PKCh. Consistent with the as…”
InfluentialmTOR at the crossroads of T cell proliferation and tolerance
Mondino, A., & Mueller, D. L. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.02.008 · Cited by 108
Co-stimulatory and co-inhibitory pathways in cancer immunotherapy
O’Neill, R., & Cao, X. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.003 · Cited by 110
So, T., Choi, H., & Croft, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003156 · Cited by 100
Semple, K., Nguyen, A., Yu, Y., Wang, H., Anasetti, C., & Yu, X.-Z. (2011) · Blood · doi:10.1182/blood-2010-08-301275 · Cited by 93
The highway code of T cell trafficking
Marelli‐Berg, F., Cannella, L., Dazzi, F., & Mirenda, V (2008) · The Journal of Pathology · doi:10.1002/path.2269 · Cited by 97
T-Cell Receptor-Induced NF-κB Activation Is Negatively Regulated by E3 Ubiquitin Ligase Cbl-b
Qiao, G., Li, Z., Molinero, L. L., Alegre, M., Ying, H., Sun, Z., Penninger, J. M., & Zhang, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01505-07 · Cited by 97
Tai, X., Van Laethem, F., Sharpe, A. H., & Singer, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706509104 · Cited by 91
Roncagalli, R., Cucchetti, M., Jarmuzynski, N., Grégoire, C., Bergot, E., Audebert, S., Baudelet, E., Menoita, M. G., Joachim, A., Durand, S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160579 · Cited by 87
“…segment contains a YMNM motif and two proline-rich motifs (PRRP and PYAP), the relative contribution of which to CD28 co-stimulatory function remains debated (Okkenhaug et al., 2001; Raab et The RLT PR signalosome | Roncagalli et al.2450 al., 2001; Kong et al., 2011; Pagán et al., 2012).”
BackgroundZhao, Y., Caron, C., Chan, Y.-Y., Lee, C. K., Xu, X., Zhang, J., Masubuchi, T., Wu, C., Bui, J. D., & Hui, E. (2023) · Immunity · doi:10.1016/j.immuni.2023.04.005 · Cited by 101
Cbl and Cbl-b in T-cell regulation
Liu, Y., & Gu, H. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02157-3 · Cited by 100
CD28 co‐signaling in the adaptive immune response
Riha, P., & Rudd, C. E. (2010) · Self/Nonself · doi:10.4161/self.1.3.12968 · Cited by 87
Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation
Ward, S. G., & Marelli‐Berg, F. M. (2009) · Biochemical Journal · doi:10.1042/bj20081969 · Cited by 86
Targeted Knock-In Mice Expressing Mutations of CD28 Reveal an Essential Pathway for Costimulation
Dodson, L. F., Boomer, J. S., Deppong, C. M., Shah, D. D., Sim, J., Bricker, T. L., Russell, J. H., & Green, J. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01869-08 · Cited by 84
PKCθ Signals Activation versus Tolerance In Vivo
Berg-Brown, N. N., Gronski, M. A., Jones, R. G., Elford, A. R., Deenick, E. K., Odermatt, B., Littman, D. R., & Ohashi, P. S. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031022 · Cited by 85
Self-citationPI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors
Dituri, F., Mazzocca, A., Giannelli, G., & Antonaci, S. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/947858 · Cited by 84
“As a consequence, p85 binds to the catalytic subunit p110 that activates PKCθ, which is capable of preventing stress-induced apoptosis of T cells [50].”
BackgroundPhysiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28
Mirenda, V., Jarmin, S. J., David, R., Dyson, J., Scott, D., Gu, Y., Lechler, R. I., Okkenhaug, K., & Marelli‐Berg, F. M. (2006) · Blood · doi:10.1182/blood-2006-10-050724 · Cited by 90
Self-citationRegulation of T‐cell responses by PTEN
Buckler, J. L., Liu, X., & Turka, L. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00650.x · Cited by 93
“However, more recent studies indicate that PI3K signaling downstream of CD28 is only required for the upregulation of the pro-survival factor BcL–xL (38). gc chain cytokines provide an additional means of activating PI3K, with IL-2 signals being the best characterized in T cells.”
BackgroundSánchez-Lockhart, M., Marin, E., Graf, B. A., Abe, R., Harada, Y., Sedwick, C. E., & Miller, J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7120 · Cited by 80
Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies
Waibler, Z., Sender, L. Y., Merten, C., Hartig, R., Kliche, S., Gunzer, M., Reichardt, P., Kalinke, U., & Schraven, B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001708 · Cited by 79
Mechanisms of T cell organotropism
Fu, H., Ward, E. J., & Marelli‐Berg, F. M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2211-4 · Cited by 85
CD28 and ICOS: Similar or separate costimulators of T cells?
van Berkel, M. E. A. T., & Oosterwegel, M. A. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.02.007 · Cited by 84
Franckaert, D., Dooley, J., Roos, E., Floess, S., Huehn, J., Luche, H., Fehling, H. J., Liston, A., Linterman, M. A., & Schlenner, S. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.108 · Cited by 76
Bjørgo, E., Solheim, S., Abrahamsen, H., Baillie, G. S., Brown, K. M., Berge, T., Okkenhaug, K., Houslay, M. D., & Taskén, K. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00696-09 · Cited by 71
Self-citationPI3Ks in Lymphocyte Signaling and Development
Okkenhaug, K., & Fruman, D. A. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_45 · Cited by 70
Self-citationHow T follicular helper cells and the germinal centre response change with age
Linterman, M. A. (2014) · Immunology & Cell Biology · doi:10.1038/icb.2013.77 · Cited by 69
Specificity and affinity motifs for Grb2 SH2-ligand interactions
Kessels, H. W. H. G., Ward, A. C., & Schumacher, T. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142224499 · Cited by 69
Acuto, O., Mise‐Omata, S., Mangino, G., & Michel, F. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00034.x · Cited by 69
“In addition to regulate T cell proliferation, a key feature of CD28 signaling is also to control major immediate and late effectors of antiapoptotic programs such as Akt, NF-kB and Bcl-XL (46, 54, 111, 112), with the net effect of increasing the number of effector and memory T cells.”
BackgroundInfluentialSuh, W., Tafuri, A., Berg-Brown, N. N., Shahinian, A., Plyte, S., Duncan, G. S., Okada, H., Wakeham, A. C., Odermatt, B., Ohashi, P. S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.5917 · Cited by 68
Self-citationWu, L., Rose, J. L., Chen, L., Neale, C., Mak, T. W., Okkenhaug, K., Wange, R. L., & Rottapel, R. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.180 · Cited by 80
Self-citationIntracellular Signals of T Cell Costimulation
Song, J. J., Lei, F., Xiong, X., & Haque, R. (2008) · Cellular and Molecular Immunology · doi:10.1038/cmi.2008.30 · Cited by 80
Friend, L. D., Shah, D. D., Deppong, C. M., Lin, J., Bricker, T. L., Juehne, T. I., Rose, C. M., & Green, J. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052230 · Cited by 66
Watanabe, R., Harada, Y., Takeda, K., Takahashi, J., Ohnuki, K., Ogawa, S., Ohgai, D., Kaibara, N., Koiwai, O., Tanabe, K., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1085 · Cited by 62
Distinct regions in the CD28 cytoplasmic domain are required for T helper type 2 differentiation
Andres, P. G., Howland, K. C., Nirula, A., Kane, L., Barron, L., Dresnek, D., Sadra, A., Imboden, J. B., Weiss, A., & Abbas, A. K. (2004) · Nature Immunology · doi:10.1038/ni1044 · Cited by 63
Moeller, M., Haynes, N. M., Trapani, J. A., Teng, M. W. L., Jackson, J. T., Tanner, J. E., Cerruti, L., Jane, S. M., Kershaw, M. H., Smyth, M. J., et al. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700710 · Cited by 62
Jung, U., Foley, J., Erdmann, A. A., Eckhaus, M., & Fowler, D. H. (2003) · Blood · doi:10.1182/blood-2002-12-3936 · Cited by 62
Cutting Edge: A Crucial Role for B7-CD28 in Transmitting T Help from APC to CTL
Prilliman, K. R., Lemmens, E. E., Palioungas, G., Wolfe, T. G., Allison, J. P., Sharpe, A. H., & Schoenberger, S. P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4094 · Cited by 55
Gogishvili, T., Lühder, F., Goebbels, S., Beer‐Hammer, S., Pfeffer, K., & Hünig, T. (2013) · European Journal of Immunology · doi:10.1002/eji.201242824 · Cited by 57
A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients
Lee, S. H., Js, K., Kim, J., Kim, S. J., Kim, W. S., Lee, S., Ko, Y. H., & Yoo, H. Y. (2015) · Haematologica · doi:10.3324/haematol.2015.133074 · Cited by 60
Taylor, A., & Rudd, C. E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01653 · Cited by 61
Zhang, N., & He, Y.-W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6967 · Cited by 60
Regulation of Thymic NKT Cell Development by the B7-CD28 Costimulatory Pathway
Williams, J. A., Lumsden, J. M., Xiang, Y., Feigenbaum, L., Zhang, J., Steinberg, S. M., & Hodes, R. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.907 · Cited by 65
Deane, J. A., Kharas, M. G., Oak, J. S., Stiles, L. N., Luo, J., Moore, T. I., Ji, H., Rommel, C., Cantley, L. C., Lane, T. E., et al. (2006) · Blood · doi:10.1182/blood-2006-07-038620 · Cited by 63
Piccolella, E., Spadaro, F., Ramoni, C., Marinari, B., Costanzo, A., Levrero, M., Thomson, L., Abraham, R. T., & Tuosto, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.2895 · Cited by 59
Staying Alive: T Cell Costimulation, CD28, and Bcl-xL
Watts, T. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1090085 · Cited by 63
Jarmin, S. J., David, R., Ma, L., Chai, J.-G., Dewchand, H., Takesono, A., Ridley, A. J., Okkenhaug, K., & Marelli‐Berg, F. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33267 · Cited by 55
Self-citationWilliams, J. A., Hathcock, K. S., Klug, D. B., Harada, Y., Choudhury, B., Allison, J. P., Abe, R., & Hodes, R. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4199 · Cited by 55
How the Discovery of the CD4/CD8-p56lck Complexes Changed Immunology and Immunotherapy
Rudd, C. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.626095 · Cited by 62
“In T-cells, TCR engagement promotes FAK and PYK2 phosphorylation and translocation to the IS (Sancho et al., 2002; Ostergaard and Lysechko, 2005; Collins et al., 2010).”
BackgroundLipid phosphatases in the regulation of T cell activation: living up to their PTEN‐tial
Seminario, M., & Wange, R. L. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00013.x · Cited by 57
Okamoto, N., Tezuka, K., Kato, M., Abe, R., & Tsuji, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.065 · Cited by 53
“In addition, an SH3-kinase binding motif, PYAP in CD28, which is independent of the YMFM motif, has an important role in IL-2 production and subsequent T-cell proliferation [38,39].”
BackgroundToxic mechanisms of the trichothecenes T-2 toxin and deoxynivalenol on protein synthesis
Li, J., Wang, Y., Deng, Y., Wang, X., Wu, W., Nepovimová, E., Wu, Q., & Kuča, K. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113044 · Cited by 52
A1 is a growth-permissive antiapoptotic factor mediating postactivation survival in T cells
Gonzalez, J., Orlofsky, A., & Prystowsky, M. B. (2003) · Blood · doi:10.1182/blood-2002-04-1229 · Cited by 52
Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
Kishore, M., Cheung, K. C.-P., Fu, H., Bonacina, F., Wang, G., Coe, D., Ward, E. J., Colamatteo, A., Jangani, M., Baragetti, A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.034 · Cited by 51
“…mice The Jackson laboratory 000651 Foxp3-GFP (Foxp3-IRES-EGFP) genetically targeted mice Dr B Malissen NA Cd28Y170F Dr Klaus Okkenhaug (Okkenhaug et al., 2001) Oligonucleotides Glucokinase (hexokinase 4) primer: F:CAACTGGACCAAGGGCTTCAA; R:TGTGGCCACCGTGTCATTC this paper NA Glut1:…”
BackgroundInfluentialSelf-citationMeasles Virus Interacts with and Alters Signal Transduction in T-Cell Lipid Rafts
Avota, E., Müller, N., Klett, M., & Schneider‐Schaulies, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9552-9559.2004 · Cited by 51
Metadata
- Authors
- Okkenhaug, K., Wu, L., Garza, K. M., La Rose, J., Khoo, W., Odermatt, B., Mak, T. W., Ohashi, P. S., & Rottapel, R.
- Affiliations
- University of Toronto (CA)
- Princess Margaret Cancer Centre (CA)
- Amgen (Canada) (CA)
- University of Zurich (CH)
- St. Michael's Hospital (CA)
- Corresponding author
- Rottapel, Robert
- Venue
- Nature Immunology
- Published
- 2001-04
- Volume
- 2
- Issue
- 4
- Pages
- 325-332
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W118130514
- Cited by
- 210
- References
- 49
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 5 · 2018: 2 · 2017: 5 · 2016: 5 · 2015: 2 · 2014: 8 · 2013: 7 · 2012: 10
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- CD28, B7, tyrosine phosphorylation, phosphatidylinositol 3-kinase, Grb2, GAD, T cell proliferation, T cell survival, Bcl-xL, radiation-induced apoptosis, T cell anergy, interleukin-2, B cell help, transgenic mice
- MeSH terms
- Animals, B-Lymphocytes, Cell Division, Cell Survival, Humans, Immunoglobulins, Interleukin-2, Lymphocyte Cooperation, Lymphocyte Activation, Mice, Inbred C57BL, Mice, Transgenic, Phosphorylation, T-Lymphocytes, Tyrosine, Signal Transduction, Gene Expression, Point Mutation, Clonal Anergy, CD28 Antigens, Mice, Knockout, src Homology Domains, Proto-Oncogene Proteins c-bcl-2, Phosphatidylinositol 3-Kinases, bcl-X Protein, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.